Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2024
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
58
-0.14%
|
$986
$17.35 P/Share
|
|
Jan 23
2024
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
336
-0.8%
|
$5,712
$17.11 P/Share
|
|
Jan 19
2024
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,419
-3.59%
|
$38,704
$16.76 P/Share
|
|
Jan 19
2024
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
2,642
-0.6%
|
$42,272
$16.76 P/Share
|
|
Jan 19
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,450
-0.52%
|
$23,200
$16.76 P/Share
|
|
Jan 19
2024
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
1,776
-2.96%
|
$28,416
$16.76 P/Share
|
|
Jan 19
2024
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
1,198
-0.96%
|
$19,168
$16.76 P/Share
|
|
Jan 19
2024
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
1,232
-1.05%
|
$19,712
$16.76 P/Share
|
|
Jan 19
2024
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
862
-2.0%
|
$13,792
$16.76 P/Share
|
|
Jan 02
2024
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
601
-0.48%
|
$9,616
$16.75 P/Share
|
|
Jan 02
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
697
-0.25%
|
$11,152
$16.75 P/Share
|
|
Jan 02
2024
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
491
-0.42%
|
$7,856
$16.75 P/Share
|
|
Dec 22
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
314
-0.46%
|
$5,024
$16.79 P/Share
|
|
Dec 17
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
228
+0.18%
|
-
|
|
Dec 17
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
254
+0.38%
|
-
|
|
Dec 17
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
705
+0.25%
|
-
|
|
Dec 17
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
211
+0.35%
|
-
|
|
Dec 03
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
258
+0.2%
|
-
|
|
Dec 03
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
796
+0.29%
|
-
|
|
Dec 03
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
229
+0.38%
|
-
|
|
Dec 03
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
287
+0.42%
|
-
|
|
Dec 01
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
303
-0.51%
|
$3,636
$12.37 P/Share
|
|
Dec 01
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
591
-0.21%
|
$7,092
$12.37 P/Share
|
|
Dec 01
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
394
-0.91%
|
$4,728
$12.37 P/Share
|
|
Dec 01
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
466
-0.37%
|
$5,592
$12.37 P/Share
|
|
Dec 01
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
666
-0.98%
|
$7,992
$12.37 P/Share
|
|
Dec 01
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
394
-0.33%
|
$4,728
$12.37 P/Share
|
|
Nov 19
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
234
+0.39%
|
-
|
|
Nov 19
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
826
+0.3%
|
-
|
|
Nov 19
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
267
+0.21%
|
-
|
|
Nov 19
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.44%
|
-
|
|
Nov 13
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
97
-0.14%
|
$970
$10.66 P/Share
|
|
Nov 13
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
132
-0.05%
|
$1,320
$10.77 P/Share
|
|
Nov 13
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
111
-0.19%
|
$1,110
$10.66 P/Share
|
|
Nov 13
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
98
-0.08%
|
$980
$10.77 P/Share
|
|
Nov 13
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
76
-0.17%
|
$760
$10.77 P/Share
|
|
Nov 13
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
114
-0.09%
|
$1,140
$10.77 P/Share
|
|
Nov 05
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
924
+0.33%
|
-
|
|
Nov 05
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
333
+0.49%
|
-
|
|
Nov 05
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
262
+0.44%
|
-
|
|
Nov 05
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
299
+0.24%
|
-
|
|
Nov 01
2023
|
Timothy L. Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
495
+2.59%
|
-
|
|
Nov 01
2023
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
598
+1.99%
|
-
|
|
Nov 01
2023
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
495
+1.54%
|
-
|
|
Nov 01
2023
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
577
+1.9%
|
-
|
|
Nov 01
2023
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
608
+1.83%
|
-
|
|
Oct 30
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
72,603
-17.3%
|
$653,427
$9.13 P/Share
|
|
Oct 22
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
373
+0.55%
|
-
|
|
Oct 22
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,034
+0.37%
|
-
|
|
Oct 22
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
771
+0.18%
|
-
|